Drug

SPC-14

Targeting Alzheimer’s

Drug

Novel drug targeting two receptor molecules.

  • Preclinical research

Unmet need:

  • Treatment market projected growth to $30.8B in 2033, at
    18.8% CAGR.

Medical needs:

  • Potential to improve and restore cognitive and memory function.
Next Drug

Competitive advantages:

  • Has shown efficacy against luteinizing hormone (LH) in
    attenuating learned helplessness, preservative behavior, and hyponeophagia (a measure of anxiety).
Next Drug

Get more information on Silo Pharma. Sign up for email alerts online.

SIGN UP